|
Merck's stock falls after disclosing government probe into asthma drug pricing
MarketWatch Merck & Co. Inc.'s stock dropped 1.5% in midday trade Friday, after the drug maker disclosed in a filing late Thursday that it had received a civil investigative demand from the U.S. Attorney's office. The demand requests information related to the … |
View full post on asthma – Google News